Voxel-based morphometry to discriminate early Alzheimer's disease from controls

Department of Radiology, National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan.
Neuroscience Letters (Impact Factor: 2.03). 08/2005; 382(3):269-74. DOI: 10.1016/j.neulet.2005.03.038
Source: PubMed


We assessed the accuracy of voxel-based morphometry (VBM) using a three-dimensional T1-weighted MRI in discriminating Alzheimer's disease (AD) in the very early stage of amnestic type of mild cognitive impairment and age-matched healthy controls. We randomly divided these subjects into two groups. The first group comprising 30 AD patients and 41 controls was used to identify the area with the most significant gray matter loss in patients compared to normal controls based on the voxel-based analysis of a group comparison. The second group comprising 31 patients and 41 controls was used to determine the discrimination accuracy of VBM. A Z-score map for a gray matter image of a subject was obtained by comparison with mean and standard deviation gray matter images of the controls for each voxel after anatomical standardization and voxel normalization to global mean using the following equation; Z-score=([control mean]-[individual value])/(control S.D.). Receiver operating characteristic curves for a Z-score in the bilateral medial temporal areas including the entorhinal cortex with the most significant loss in the first group showed a high discrimination accuracy of 87.8%. This result would open up a possibility for early diagnosis of AD using VBM.

Download full-text


Available from: Kiyotaka Nemoto, Jul 02, 2015
  • Source
    • "Then, gray matter images were smoothed with an isotropic Gaussian kernel with a full-width-at-half-maximum of 12 mm. We compared the gray matter images of each subject with the mean and standard deviation of gray matter images obtained from healthy older adults using voxel-by-voxel Z-score analysis (Hirata et al., 2005; Matsuda et al., 2012). Regions of brain atrophy were defined as voxels with a Z-score N 2. A brain atrophy index was defined as the proportion of atrophic voxels relative to the total number of voxels for the entire brain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Physical activity may help to prevent or delay brain atrophy. Numerous studies have shown associations between physical activity and age-related changes in the brain. However, most of these studies involved self-reported physical activity, not objectively measured physical activity. Therefore, the aim of this study was to examine the association between objectively measured physical activity, as determined using accelerometers, and brain magnetic resonance imaging (MRI) measures in older adults with mild cognitive impairment (MCI). We analyzed 323 older subjects with MCI (mean age 71.4years) who were recruited from the participants of the Obu Study of Health Promotion for the Elderly. We recorded demographic data and measured physical activity using a tri-axial accelerometer. Physical activity was classified as light-intensity physical activity (LPA) or moderate-to-vigorous physical activity (MVPA). Brain atrophy and the severity of white matter lesions (WML) were determined by MRI. Low levels of LPA and MVPA were associated with severe WML. Subjects with severe WML were older, had lower mobility, and had greater brain atrophy than subjects with mild WML (all P<0.05). Multivariate analysis revealed that more MVPA was associated with less brain atrophy, even after adjustment for WML (β=-0.126, P=0.015), but LPA was not (β=-0.102, P=0.136). Our study revealed that objectively measured physical activity, especially MVPA, was associated with brain atrophy in MCI subjects, even after adjusting for WML. These findings support the hypothesis that physical activity plays a crucial role in maintaining brain health. Copyright © 2014 Elsevier Inc. All rights reserved.
    Experimental Gerontology 12/2014; 62C:1-6. DOI:10.1016/j.exger.2014.12.011 · 3.49 Impact Factor
  • Source
    • "Although the amyloid and tau imaging methods enable direct observation of AD pathogenesis, they are not appropriate methods for easily screening dementia in most hospitals and are still not easily applied in clinical practice. In that regard, VBM-MRI that could detect AD-specific structural brain changes, especially medial temporal atrophy (MTA) [8] [9] [10] [11], and magnetic resonance spectroscopy ( 1 H MRS) using regular 1.5-Tesla (T) MRI that captures early brain biochemical abnormalities, are popular, non-invasive, cost-effective, require a short examination time, and are practical for early diagnosis and for tracking subjects with dementia due to AD [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32]. Previous studies have shown the utility of VBM-MRI for showing MTA and metabolite abnormalities on 1 H MRS for the early diagnosis of MCI and AD [8–11, 19–33]. "

    Alzheimer's and Dementia 07/2014; 10(4):P717-P718. DOI:10.1016/j.jalz.2014.05.1327 · 12.41 Impact Factor
  • Source
    • "At the very early stage of AD, regional cortical atrophy is mainly restricted to the medial temporal structures as well as the posterior cingulate gyrus [44,45,46]. With the progression of the disease, the atrophic areas extend to the parietal and frontal lobes with the advancement of the disease [47,48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Trail Making Test (TMT) has long been used to investigate deficits in cognitive processing speed and executive function in humans. However, there are few studies that elucidate the neural substrates of the TMT. The aim of the present study was to identify the regional perfusion patterns of the brain associated with performance on the TMT part A (TMT-A) in patients with Alzheimer's disease (AD). Eighteen AD patients with poor performance on the TMT-A and 36 age- and sex-matched AD patients with good performance were selected. All subjects underwent brain single photon emission computed tomography. No significant differences between the good and poor performance groups were found with respect to years of education and revised Addenbrooke's Cognitive Examination scores. However, higher z-scores for hypoperfusion in the bilateral superior parietal lobule were observed in the group that scored poorly on the TMT-A compared with the good performance group. Our results suggest that functional activity of the bilateral superior parietal lobules is closely related to performance time on the TMT-A. Thus, the performance time on the TMT-A might be a promising index of dysfunction of the superior parietal area among mild AD patients.
    06/2013; 3(1):202-11. DOI:10.1159/000350806
Show more